首页> 外国专利> Tablet featurated by controllable release of alphusozine hydrochloride contained therein

Tablet featurated by controllable release of alphusozine hydrochloride contained therein

机译:通过可控地释放其中所含的盐酸盐酸阿普齐嗪来使片剂达到最佳状态

摘要

Tablets for oral administration comprise a) a first layer 1 that swells noticeably and rapidly on contact with aqueous biological fluids, the layer being prepared by compression of a mixture or granules having 5 - 90% by weight (pref. 10 - 85%) of hydrophilic polymers, b) a second layer 2 that is adjacent to or superposed on 1, containing alfuzosin hydrochloride (I), hydrophilic polymers, and auxiliary materials that give the mixture compressibility whilst allowing liberation of (I) over a predetermined period, and optionally c) a third layer 3 that is compressed and applied over 2 which is mainly hydrophilic polymers that gel and/or swell and which may erode, having the effect of modifying liberation of (I) from layer 2, this layer 3 being only slightly permeable to (I) these tablets giving controlled liberation of (I) at the proximal segments of the gastrointestinal tract (duodenum and jejunum).
机译:用于口服的片剂包括:a)第一层1,其在与水性生物流体接触时显着且迅速溶胀,该层是通过压缩具有5-90重量%(优选10-85%)重量的混合物或颗粒来制备的。亲水性聚合物; b)与1相邻或叠置的第二层2,其中包含盐酸阿夫唑嗪(I),亲水性聚合物和辅助材料,这些混合物可提供混合物可压缩性,同时允许在预定时间内释放(I),并且c)被压缩并施加在2上的第三层3,其主要是凝胶和/或溶胀并可能腐蚀的亲水性聚合物,具有改变(I)从层2释放的作用,该层3仅是微渗透性的至(I)这些片剂在胃肠道的近端部分(十二指肠和空肠)给予(I)受控的释放。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号